Salat-Baroux J, Alvarez S, Antoine J M, Tibi C, Cornet D, Mandelbaum J, Plachot M, Junca A M
Chaire de Gynécologie Obstétrique et Biologie de la Reproduction, Hôpital Tenon, Paris, France.
Hum Reprod. 1988 May;3(4):535-9. doi: 10.1093/oxfordjournals.humrep.a136740.
Two groups of patients with polycystic ovary disease were treated with analogues of LHRH to compare long and short protocols of pituitary desensitization. In group 1 (n = 15), decapeptyl was administered for 30 days associated with stimulation by pure FSH. In group 2 (n = 12) Buserelin was given for 15 days with the same ovarian stimulation. Patients were randomly assigned to the two groups. Six patients in each group had received treatment, for at least 4 months, to induce ovulation with clomiphene citrate or HMG and failed to conceive, despite the absence of a tubal factor. The best results were obtained using the long protocol. Androgen concentrations, particularly delta 4-androstenedione, were significantly lower on the day of oocyte retrieval in group 1 than in group 2 (2.52 +/- 0.73 ng/ml versus 4.44 +/- 2.62, respectively (P less than 0.02). Polycystic follicular formation was less pronounced in group 1 and no clinical hyperstimulations occurred in this group. The pregnancy rate was comparable in the two groups (six ongoing pregnancies in 21 cycles in the 15 patients in group 1 versus three pregnancies in 12 cycles in the 12 patients in group 2).
两组多囊卵巢疾病患者接受促黄体生成素释放激素(LHRH)类似物治疗,以比较垂体脱敏的长方案和短方案。在第1组(n = 15)中,使用十肽(达必佳)治疗30天,并联合使用纯促卵泡生成素(FSH)进行刺激。在第2组(n = 12)中,使用布舍瑞林治疗15天,并进行相同的卵巢刺激。患者被随机分配到两组。每组中有6名患者曾接受至少4个月的枸橼酸氯米芬或人绝经期促性腺激素(HMG)诱导排卵治疗,但尽管不存在输卵管因素仍未受孕。使用长方案获得了最佳结果。在取卵当天,第1组的雄激素浓度,尤其是△4-雄烯二酮,显著低于第2组(分别为2.52±0.73 ng/ml和4.44±2.62 ng/ml,P<0.02)。第1组的多囊卵泡形成不那么明显,且该组未发生临床过度刺激。两组的妊娠率相当(第1组15名患者的21个周期中有6例持续妊娠,第2组12名患者的12个周期中有3例妊娠)。